Delve Insight
Delve Insight Market Research Reports
| Title | published | price | |
|---|---|---|---|
Afinitor (everolimus) - Drug Insight and Market Forecast - 2030By Delve Insight
Overview "Afinitor (everolimus) - Drug Insight and Market Forecast - 2030" report by DelveInsight outlays comprehensive insights of the product indicated for the treatment of its approved condition. A detailed picture of the Afinitor ( ... |
20-Feb-2020 | $2750 | |
Alphanate - Drug Insight and Market Forecast - 2030By Delve Insight
Overview "Alphanate - Drug Insight and Market Forecast - 2030" report by DelveInsight outlays comprehensive insights of the product indicated for the treatment of its approved condition. A detailed picture of the Alphanate in Seven Maj ... |
20-Feb-2020 | $2750 | |
Benlysta (belimumab) - Drug Insight and Market Forecast - 2030By Delve Insight
Overview "Benlysta (belimumab) - Drug Insight and Market Forecast - 2030" report by DelveInsight outlays comprehensive insights of the product indicated for the treatment of its approved condition. A detailed picture of the Benlysta (b ... |
20-Feb-2020 | $2750 | |
Doptelet (avatrombopag) - Drug Insight and Market Forecast - 2030By Delve Insight
Overview "Doptelet (avatrombopag) - Drug Insight and Market Forecast - 2030" report by DelveInsight outlays comprehensive insights of the product indicated for the treatment of its approved condition. A detailed picture of the Doptelet ... |
20-Feb-2020 | $2750 | |
Epidiolex (cannabidiol) - Drug Insight and Market Forecast - 2030By Delve Insight
Overview "Epidiolex (cannabidiol) - Drug Insight and Market Forecast - 2030" report by DelveInsight outlays comprehensive insights of the product indicated for the treatment of its approved condition. A detailed picture of the Epidiole ... |
20-Feb-2020 | $2750 | |
Esbriet (pirfenidone) - Drug Insight and Market Forecast - 2030By Delve Insight
Overview "Esbriet (pirfenidone) - Drug Insight and Market Forecast - 2030" report by DelveInsight outlays comprehensive insights of the product indicated for the treatment of its approved condition. A detailed picture of the Esbriet (p ... |
20-Feb-2020 | $2750 | |
Firdapse (amifampridine) - Drug Insight and Market Forecast - 2030By Delve Insight
Overview "Firdapse (amifampridine) - Drug Insight and Market Forecast - 2030" report by DelveInsight outlays comprehensive insights of the product indicated for the treatment of its approved condition. A detailed picture of the Firdaps ... |
20-Feb-2020 | $2750 | |
Hemlibra (emicizumab-kxwh) - Drug Insight and Market Forecast - 2030By Delve Insight
Overview "Hemlibra - Drug Insight and Market Forecast2030" report by DelveInsight outlays comprehensive insights of the product based on routine prophylaxis to prevent or reduce the frequency of bleeding ... |
20-Feb-2020 | $2750 | |
Ibrance (palbociclib) - Drug Insight and Market Forecast - 2030By Delve Insight
Overview "Ibrance- Drug Insight and Market Forecast 2030" report by DelveInsight outlays comprehensive insights of the product indicated for the treatment of Hormone Receptor positive (HR+), Human Epidermal Growth Factor Receptor 2 n ... |
20-Feb-2020 | $2750 | |
Imbruvica (ibrutinib) - Drug Insight and Market Forecast - 2030By Delve Insight
Overview "Imbruvica (ibrutinib) - Drug Insight and Market Forecast - 2030" report by DelveInsight outlays comprehensive insights of the product indicated for the treatment of its approved condition. A detailed picture of the Imbruvica ... |
20-Feb-2020 | $2750 | |
Kisqali (ribociclib) - Drug Insight and Market Forecast - 2030By Delve Insight
Overview "Kisqali (ribociclib) - Drug Insight and Market Forecast - 2030" report by DelveInsight outlays comprehensive insights of the product indicated for the treatment of its approved condition. A detailed picture of the Kisqali (ri ... |
20-Feb-2020 | $2750 | |
Lumizyme (alglucosidase alfa) - Drug Insight and Market Forecast - 2030By Delve Insight
Overview "Lumizyme (alglucosidase alfa) - Drug Insight and Market Forecast - 2030" report by DelveInsight outlays comprehensive insights of the product indicated for the treatment of its approved condition. A detailed picture of the Lu ... |
20-Feb-2020 | $2750 | |
Luxturna (voretigene neparvovec-rzyl) - Drug Insight and Market Forecast - 2030By Delve Insight
Overview "Luxturna (voretigene neparvovec-rzyl) - Drug Insight and Market Forecast - 2030" report by DelveInsight outlays comprehensive insights of the product indicated for the treatment of its approved condition. A detailed picture o ... |
20-Feb-2020 | $2750 | |
Nexavar (sorafenib) - Drug Insight and Market Forecast - 2030By Delve Insight
Overview "Nexavar (sorafenib) - Drug Insight and Market Forecast - 2030" report by DelveInsight outlays comprehensive insights of the product indicated for the treatment of its approved condition. A detailed picture of the Nexavar (sor ... |
20-Feb-2020 | $2750 | |
Nplate (romiplostim) Romiplate - Drug Insight and Market Forecast - 2030By Delve Insight
Overview "Nplate (romiplostim)Romiplate - Drug Insight and Market Forecast - 2030" report by DelveInsight outlays comprehensive insights of the product indicated for the treatment of its approved condition. A detailed picture of the Np ... |
20-Feb-2020 | $2750 | |
Ofev (nintedanib) - Drug Insight and Market Forecast - 2030By Delve Insight
Overview "Ofev (nintedanib) - Drug Insight and Market Forecast - 2030" report by DelveInsight outlays comprehensive insights of the product indicated for the treatment of its approved condition. A detailed picture of the Ofev (nintedan ... |
20-Feb-2020 | $2750 | |
Prevymis (letermovir) - Drug Insight and Market Forecast - 2030By Delve Insight
Overview "Prevymis (letermovir) - Drug Insight and Market Forecast - 2030" report by DelveInsight outlays comprehensive insights of the product indicated for the treatment of its approved condition. A detailed picture of the Prevymis ( ... |
20-Feb-2020 | $2750 | |
Promacta/Revolade (eltrombopag) - Drug Insight and Market Forecast - 2030By Delve Insight
Overview "Promacta/Revolade (eltrombopag) - Drug Insight and Market Forecast - 2030" report by DelveInsight outlays comprehensive insights of the product indicated for the treatment of its approved condition. A detailed picture of the ... |
20-Feb-2020 | $2750 | |
Rhopressa (netarsudil ophthalmic solution) - Drug Insight and Market Forecast - 2030By Delve Insight
Overview "Rhopressa (netarsudil ophthalmic solution) - Drug Insight and Market Forecast - 2030" report by DelveInsight outlays comprehensive insights of the product indicated for the treatment of its approved condition. A detailed pict ... |
20-Feb-2020 | $2750 | |
Rocklatan (netarsudil and latanoprost ophthalmic solution) - Drug Insight and Market Forecast - 2030By Delve Insight
Overview "Rocklatan (netarsudil and latanoprost ophthalmic solution) - Drug Insight and Market Forecast - 2030" report by DelveInsight outlays comprehensive insights of the product indicated for the treatment of its approved condition. ... |
20-Feb-2020 | $2750 | |
- + 1 888 391 5441
- [email protected]
